{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:31:17Z","timestamp":1793946677958,"version":"4.8.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004607","name":"Guangxi Natural Science Foundation","doi-asserted-by":"publisher","award":["2025GXNSFBA069082"],"award-info":[{"award-number":["2025GXNSFBA069082"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFA1300904"],"award-info":[{"award-number":["2021YFA1300904"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013262","name":"State Key Laboratory of Respiratory Disease","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013262","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bmc.2026.118663","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T08:30:55Z","timestamp":1775896255000},"page":"118663","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Development of Thieno[2,3-b]pyridin-6(7H)-one derivatives against drug-resistant Mycobacterium tuberculosis"],"prefix":"10.1016","volume":"138","author":[{"given":"Qin","family":"Zha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew B.","family":"McNeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niuniu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2026.118663_bb0005","doi-asserted-by":"crossref","first-page":"7579","DOI":"10.1021\/acs.jmedchem.5c00049","article-title":"Structure of mycobacterial NDH-2 bound to a 2-mercapto-quinazolinone inhibitor","volume":"68","author":"Liang","year":"2025","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118663_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115571","article-title":"Design, synthesis and biological evaluation of 3-substituted-2-thioxothiazolidin-4-one (rhodanine) derivatives as antitubercular agents against mycobacterium tuberculosis protein tyrosine phosphatase b","volume":"258","author":"Cheng","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118663_bb0015","series-title":"Global Tuberculosis Report 2025","author":"World Health Organization","year":"2025"},{"key":"10.1016\/j.bmc.2026.118663_bb0020","doi-asserted-by":"crossref","first-page":"16459","DOI":"10.1021\/acs.jmedchem.5c01331","article-title":"Design and development of lysyl tRNA synthetase inhibitors, for the treatment of tuberculosis","volume":"68","author":"Davis","year":"2025","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118663_bb0025","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/s41586-025-09286-3","article-title":"SuFEx-based antitubercular compound irreversibly inhibits pks13","volume":"645","author":"Krieger","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2026.118663_bb0030","doi-asserted-by":"crossref","first-page":"21633","DOI":"10.1021\/acs.jmedchem.4c02876","article-title":"Move over COVID, tuberculosis is once again the leading cause of death from a single infectious disease","volume":"67","author":"Berida","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118663_bb0035","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41573-024-00933-4","article-title":"Combating antimicrobial resistance in malaria, HIV and tuberculosis","volume":"23","author":"Duffey","year":"2024","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmc.2026.118663_bb0040","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.apsb.2025.01.023","article-title":"Revolutionizing tuberculosis treatment: breakthroughs, challenges, and hope on the horizon","volume":"15","author":"Kufa","year":"2025","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.bmc.2026.118663_bb0045","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/S2213-2600(23)00426-5","article-title":"Bedaquiline, pretomanid, and linezolid with or without moxifloxacin for tuberculosis","volume":"12","author":"Labuda","year":"2024","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.bmc.2026.118663_bb0050","doi-asserted-by":"crossref","first-page":"118010","DOI":"10.1016\/j.ejmech.2025.118010","article-title":"Discovery of novel cytochrome bd oxidase inhibitors against mycobacterium tuberculosis","volume":"298","author":"Wu","year":"2025","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118663_bb0055","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jobb.2024.01.001","article-title":"Emerging bedaquiline resistance: a threat to the global fight against drug-resistant tuberculosis","volume":"6","author":"Satapathy","year":"2024","journal-title":"Journal of Biosafety and Biosecurity"},{"key":"10.1016\/j.bmc.2026.118663_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114916","article-title":"Expanding the knowledge around antitubercular 5-(2-aminothiazol-4-yl) isoxazole-3-carboxamides: hit\u2013to\u2013lead optimization and release of a novel antitubercular chemotype via scaffold derivatization","volume":"245","author":"Girardini","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118663_bb0065","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1021\/acs.jmedchem.3c01892","article-title":"Unraveling dilemmas and lacunae in the escalating drug resistance of mycobacterium tuberculosis to bedaquiline, delamanid, and pretomanid","volume":"67","author":"Negi","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118663_bb0070","doi-asserted-by":"crossref","first-page":"15380","DOI":"10.1021\/acs.jmedchem.3c01514","article-title":"Identification and optimization of novel inhibitors of the polyketide synthase 13 thioesterase domain with antitubercular activity","volume":"66","author":"Green","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118663_bb0075","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1021\/acsinfecdis.8b00225","article-title":"Pyrazolo [1, 5-a] pyridine inhibitor of the respiratory cytochrome bcc complex for the treatment of drug-resistant tuberculosis","volume":"5","author":"Lu","year":"2018","journal-title":"ACS Infectious Diseases"},{"key":"10.1016\/j.bmc.2026.118663_bb0080","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/AAC.02020-19","article-title":"OPC-167832, a novel carbostyril derivative with potent antituberculosis activity as a DprE1 inhibitor","volume":"64","author":"Hariguchi","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2026.118663_bb0085","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01294-22","article-title":"Cyclic AMP-mediated inhibition of cholesterol catabolism in mycobacterium tuberculosis by the novel drug candidate GSK2556286","volume":"67","author":"Brown","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2026.118663_bb0090","doi-asserted-by":"crossref","first-page":"8011","DOI":"10.1021\/acs.jmedchem.7b00631","article-title":"Discovery of a potent and specific m. tuberculosis leucyl-tRNA synthetase inhibitor: (S)-3-(aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)-ol (GSK656)","volume":"60","author":"Li","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118663_bb0095","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/AAC.00974-21","article-title":"In vitro and in vivo activity of oxazolidinone candidate OTB-658 against mycobacterium tuberculosis","volume":"65","author":"Guo","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2026.118663_bb0100","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1056\/NEJMoa1313865","article-title":"Multidrug-resistant tuberculosis and culture conversion with bedaquiline","volume":"371","author":"Diacon","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmc.2026.118663_bb0105","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nbt0213-89","article-title":"First novel anti-tuberculosis drug in 40 years","volume":"31","author":"Osborne","year":"2013","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.bmc.2026.118663_bb0110","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1007\/s40265-019-01207-9","article-title":"Pretomanid: first approval","volume":"79","author":"Keam","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.bmc.2026.118663_bb0115","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s40265-014-0241-5","article-title":"H. Delamanid: first global approval","volume":"74","author":"Ryan","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.bmc.2026.118663_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116806","article-title":"Design and synthesis of thieno[3, 2-b]pyridinone derivatives exhibiting potent activities against mycobacterium tuberculosis in vivo by targeting Enoyl-ACP reductase","volume":"279","author":"Liang","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118663_bb0125","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1021\/jm0503493","article-title":"Synthesis of thieno[2, 3-b]pyridinones acting as cytoprotectants and as inhibitors of [3H] glycine binding to the N-methyl-D-aspartate (NMDA) receptor","volume":"49","author":"Buchstaller","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118663_bb0130","doi-asserted-by":"crossref","first-page":"8851","DOI":"10.1021\/ja504361y","article-title":"Cu-catalyzed cascades to carbocycles: union of diaryliodonium salts with alkenes or alkynes exploiting remote carbocations","volume":"136","author":"Zhang","year":"2014","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2026.118663_bb0135","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1039\/c2ta01318e","article-title":"C\u2013H activation: making diketopyrrolopyrrole derivatives easily accessible","volume":"1","author":"Liu","year":"2013","journal-title":"J Mater Chem A"},{"key":"10.1016\/j.bmc.2026.118663_bb0140","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/13543776.2023.2262138","article-title":"CDC7 kinase inhibitors: a survey of recent patent literature (2017\u20132022)","volume":"33","author":"Irie","year":"2023","journal-title":"Expert Opinion on Therapeutic Patents"},{"key":"10.1016\/j.bmc.2026.118663_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116579","article-title":"Molecular hybridization used to design and synthesize neo-tanshinlactone derivatives as PD-1\/PD-L1 inhibitors","volume":"54","author":"Zhang","year":"2022","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2026.118663_bb0150","article-title":"Autoluminescent mycobacterium tuberculosis for rapid, real-time, non-invasive assessment of drug and vaccine efficacy","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bmc.2026.118663_bb0155","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/imr.12266","article-title":"Macrophage defense mechanisms against intracellular bacteria","volume":"264","author":"Weiss","year":"2015","journal-title":"Immunol Rev"},{"key":"10.1016\/j.bmc.2026.118663_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.790583","article-title":"Identification of novel chemical scaffolds that inhibit the growth of mycobacterium tuberculosis in macrophages","volume":"12","author":"Ahmed","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bmc.2026.118663_bb0165","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/17460441.2020.1707801","article-title":"In vitro drug discovery models for mycobacterium tuberculosis relevant for host infection","volume":"15","author":"Parish","year":"2020","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.bmc.2026.118663_bb0170","first-page":"193","article-title":"Structures of mycobacterium tuberculosis isoprenyl diphosphate synthase rv2173 in substrate-bound forms","volume":"81","author":"Titterington","year":"2025","journal-title":"International Union of Crystallography Journal"},{"key":"10.1016\/j.bmc.2026.118663_bb0175","doi-asserted-by":"crossref","unstructured":"Abe, T., Ozaki, S., Ueda, D., Sato, T. Insight into isoprenoid biosynthesis by functional analysis of isoprenyl diphosphate synthases from mycobacterium vanbaalenii and mycobacterium tuberculosis. Chembiochem: A European J Chem Biol, 21 (2020) 2931\u20132938, ChemBioChem.","DOI":"10.1002\/cbic.202000235"},{"key":"10.1016\/j.bmc.2026.118663_bb0180","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.03559-21","article-title":"The role of fatty acid metabolism in drug tolerance of mycobacterium tuberculosis","volume":"13","author":"Quinonez","year":"2022","journal-title":"MBio"},{"key":"10.1016\/j.bmc.2026.118663_bb0185","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11010-006-9119-5","article-title":"The phosphoenolpyruvate carboxykinase of mycobacterium tuberculosis induces strong cell-mediated immune responses in mice","volume":"288","author":"Liu","year":"2006","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.bmc.2026.118663_bb0190","doi-asserted-by":"crossref","first-page":"9819","DOI":"10.1073\/pnas.1000715107","article-title":"Gluconeogenic carbon flow of tricarboxylic acid cycle intermediates is critical for mycobacterium tuberculosis to establish and maintain infection","volume":"107","author":"Marrero","year":"2010","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bmc.2026.118663_bb0195","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1039\/C8MD00212F","article-title":"Design, synthesis, and biological evaluation of m-amidophenol derivatives as a new class of antitubercular agents","volume":"9","author":"Zhang","year":"2018","journal-title":"Med Chem Commun"},{"key":"10.1016\/j.bmc.2026.118663_bb0200","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3010597","article-title":"Direct inhibitors of InhA are active against mycobacterium tuberculosis","volume":"7","author":"Manjunatha","year":"2015","journal-title":"Sci Transl Med"}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626001197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626001197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:01:00Z","timestamp":1793944860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089626001197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":40,"alternative-id":["S0968089626001197"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118663","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of Thieno[2,3-b]pyridin-6(7H)-one derivatives against drug-resistant Mycobacterium tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118663","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118663"}}